Azmiro — Medica
Gender-dysphoric/gender-incongruent persons undergoing female-to-male gender reassignment (endocrinologic masculinization)
Initial criteria
- Approve for 1 year if prescribed by or in consultation with an endocrinologist or a physician who specializes in the treatment of transgender patients.
Approval duration
1 year